These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7624744)

  • 1. [Rhabdomyolysis in patients treated with simvastatin and cyclosporin: role of the hepatic cytochrome P450 enzyme system activity].
    Meier C; Stey C; Brack T; Maggiorini M; Risti B; Krähenbühl S
    Schweiz Med Wochenschr; 1995 Jul; 125(27-28):1342-6. PubMed ID: 7624744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductase inhibitor therapy of hypercholesterolemia.
    Kreisberg RA
    Trans Am Clin Climatol Assoc; 1991; 102():153-63; discussion 163-5. PubMed ID: 2130558
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A.
    Regazzi MB; Iacona I; Campana C; Gavazzi A; Viganò M; Perani G
    Transplant Proc; 1994 Oct; 26(5):2644-5. PubMed ID: 7940825
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy].
    Blaison G; Weber JC; Sachs D; Korganow AS; Martin T; Kretz JG; Pasquali JL
    Rev Med Interne; 1992; 13(1):61-3. PubMed ID: 1410877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis.
    Lasocki A; Vote B; Fassett R; Zamir E
    Ocul Immunol Inflamm; 2007; 15(4):345-6. PubMed ID: 17763133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hypercholesterolemia after heart transplantation with the HMG-CoA reductase inhibitor simvastatin in long-term follow-up].
    Wenke K; Thiery J; Meiser B; Arndtz N; Seidel D; Reichart B
    Z Kardiol; 1995 Feb; 84(2):130-6. PubMed ID: 7717016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Worldwide experience with simvastatin/lovastatin.
    Walker JF
    Eur Heart J; 1992 Jul; 13 Suppl B():21-2. PubMed ID: 1644097
    [No Abstract]   [Full Text] [Related]  

  • 8. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-interaction-induced rhabdomyolysis.
    Segaert MF; De Soete C; Vandewiele I; Verbanck J
    Nephrol Dial Transplant; 1996 Sep; 11(9):1846-7. PubMed ID: 8918636
    [No Abstract]   [Full Text] [Related]  

  • 10. [Transplant coronary artery disease--treatment with statins].
    Wolszakiewicz J; Bilińska M
    Pol Merkur Lekarski; 2004 May; 16(95):472-3. PubMed ID: 15518430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rhabdomyolysis due to simvastin. Apropos of a case with review of the literature].
    Dromer C; Vedrenne C; Billey T; Pages M; Fournié B; Fournié A
    Rev Rhum Mal Osteoartic; 1992 Apr; 59(4):281-3. PubMed ID: 1496277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Side effects of cholesterol synthesis inhibitors].
    Wolterbeek R; Stricker BH
    Ned Tijdschr Geneeskd; 1993 May; 137(19):973-7. PubMed ID: 8497334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychiatric disorders with use of simvastatin].
    Duits N; Bos FM
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1312-5. PubMed ID: 8345888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis associated with the combined use of hydroxymethylglutaryl-coenzyme A reductase inhibitors with gemfibrozil and macrolide antibiotics.
    Landesman KA; Stozek M; Freeman NJ
    Conn Med; 1999 Aug; 63(8):455-7. PubMed ID: 10500341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Rhabdomyolysis and acute renal failure secondary to statins].
    Borrego FJ; Liébana A; Borrego J; Pérez del Barrio P; Gil JM; García Cortés MJ; Sánchez Perales C; Serrano P; Pérez Bañasco V
    Nefrologia; 2001; 21(3):309-13. PubMed ID: 11471312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhabdomyolysis following cerivastatin monotherapy--implications for therapy with HMG-CoA reductase inhibitors].
    Sparing R; Sellhaus B; Noth J; Block F
    Nervenarzt; 2003 Feb; 74(2):167-71. PubMed ID: 12596018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.
    Maxa JL; Melton LB; Ogu CC; Sills MN; Limanni A
    Ann Pharmacother; 2002 May; 36(5):820-3. PubMed ID: 11978159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.
    Molden E; Andersson KS
    Pharmacotherapy; 2007 Apr; 27(4):603-7. PubMed ID: 17381388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G; Rusconi C; Faggiano P; Sabatini T; Oneglia C; Gardini A
    Minerva Cardioangiol; 1993 Mar; 41(3):105-9. PubMed ID: 8510811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of adverse events with HMG-CoA reductase inhibitors in liver transplant patients.
    Martin JE; Cavanaugh TM; Trumbull L; Bass M; Weber F; Aranda-Michel J; Hanaway M; Rudich S
    Clin Transplant; 2008; 22(1):113-9. PubMed ID: 18217912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.